General Information of the Protein
Protein ID
PT01443
Protein Name
Polyamine deacetylase HDAC10
Secondarily
Protein Name
Histone deacetylase 10
Gene Name
HDAC10
Sequence
MGTALVYHEDMTATRLLWDDPECEIERPERLTAALDRLRQRGLEQRCLRLSAREASEEELGLVHSPEYVSLVRETQVLGKEELQALSGQFDAIYFHPSTFHCARLAAGAGLQLVDAVLTGAVQNGLALVRPPGHHGQRAAANGFCVFNNVAIAAAHAKQKHGLHRILVVDWDVHHGQGIQYLFEDDPSVLYFSWHRYEHGRFWPFLRESDADAVGRGQGLGFTVNLPWNQVGMGNADYVAAFLHLLLPLAFEFDPELVLVSAGFDSAIGDPEGQMQATPECFAHLTQLLQVLAGGRVCAVLEGGYHLESLAESVCMTVQTLLGDPAPPLSGPMAPCQSALESIQSARAAQAPHWKSLQQQDVTAVPMSPSSHSPEGRPPPLLPGGPVCKAAASAPSSLLDQPCLCPAPSVRTAVALTTPDITLVLPPDVIQQEASALREETEAWARPHESLAREEALTALGKLLYLLDGMLDGQVNSGIAATPASAAAATLDVAVRRGLSHGAQRLLCVALGQLDRPPDLAHDGRSLWLNIRGKEAAALSMFHVSTPLPVMTGGFLSCILGLVLPLAYGFQPDLVLVALGPGHGLQGPHAALLAAMLRGLAGGRVLALLEENSTPQLAGILARVLNGEAPPSLGPSSVASPEDVQALMYLRGQLEPQWKMLQCHPHLVA
    Show/Hide
Organism
Homo sapiens, Human
Protein Classification
Epigenetic regulator
>
Eraser
>
Histone deacetylase
>
HDAC class IIb
Function
Polyamine deacetylase (PDAC), which acts preferentially on N(8)-acetylspermidine, and also on acetylcadaverine and acetylputrescine (PubMed:28516954). Exhibits attenuated catalytic activity toward N(1),N(8)-diacetylspermidine and very low activity, if any, toward N(1)-acetylspermidine (PubMed:28516954). Histone deacetylase activity has been observed in vitro (PubMed:11861901, PubMed:11726666, PubMed:11677242, PubMed:11739383). Has also been shown to be involved in MSH2 deacetylation (PubMed:26221039). The physiological relevance of protein/histone deacetylase activity is unclear and could be very weak (PubMed:28516954). May play a role in the promotion of late stages of autophagy, possibly autophagosome-lysosome fusion and/or lysosomal exocytosis in neuroblastoma cells (PubMed:23801752, PubMed:29968769). May play a role in homologous recombination (PubMed:21247901). May promote DNA mismatch repair (PubMed:26221039).
    Show/Hide
Uniprot ID
Primary ID:
Q969S8

Secondarily ID:
Q08AP4
Q6STF9
Q96P77
Q96P78
Q9H028
Q9UGX1
Q9UGX2
    Show/Hide
Ensembl ID
ENSG00000100429
HGNC ID
HGNC:18128
Subcellular Location
Cytoplasm
Nucleus
Map of Molecular Bioactivity Related to the Protein
Map of Molecular Bioactivity Related to the Protein

Protein
Cell Line
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Protein
Cell Line ID: CL000023 , BTI-Tn-5B1-4
Compound ID Compound Name Compound Formula
CP0444962
5-cyclopropyl-N-[(1S)-1-[4-(hydroxycarbamoyl)phenyl]ethyl]-2-(5-phenyl-1,3-thiazol-2-yl)-1,3-thiazole-4-carboxamide
   Show/Hide
C25H22N4O3S2
 1
1
IC50 = 1.98 nM
   TI
   LI
   LO
   TS
CP0003580
Faridak
   Show/Hide
C21H23N3O2
 1
1
IC50 = 10.24 nM
   TI
   LI
   LO
   TS
Biochemical Assays
Compound ID Compound Name Compound Formula
CP0008777
JNJ-26481585
   Show/Hide
C21H26N6O2
 6
1 IC50 = 0.46 nM
2 IC50 = 0.5 nM
3 IC50 = 2.8 nM
4 IC50 = 10 nM
5 Ki = 0.05 nM
6 Ki = 4.4 nM
CP0003580
Faridak
   Show/Hide
C21H23N3O2
 5
1 IC50 = 2.1 nM
2 IC50 = 2.3 nM
3 IC50 = 4 nM
4 Ki = 5.1 nM
5 Ki = 31 nM
CP0003676
N-hydroxy-2-[[2-(6-methoxypyridin-3-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl-methylamino]pyrimidine-5-carboxamide
   Show/Hide
C23H24N8O4S
 2
1 IC50 = 2.8 nM
2 IC50 = 3 nM
CP0004941
N-hydroxy-4-[[3-(pyrrolidin-1-ylmethyl)indol-1-yl]methyl]benzamide
   Show/Hide
C21H23N3O2
 1
1 IC50 = 3.981 nM
CP0008445
3-[(dimethylamino)methyl]-N-{2-[4-(hydroxycarbamoyl)phenoxy]ethyl}-1-benzofuran-2-carboxamide
   Show/Hide
C21H23N3O5
 4
1 IC50 = 3.981 nM
2 IC50 = 52 nM
3 Ki = 20 nM
4 Ki = 24 nM
CP0005479
CHEBI:46024
   Show/Hide
C17H22N2O3
 15
1 IC50 = 5 nM
2 IC50 = 8 nM
3 IC50 = 11.3 nM
4 IC50 = 20 nM
5 IC50 = 20.1 nM
6 IC50 = 22.8 nM
7 IC50 = 31 nM
8 IC50 = 32 nM
9 IC50 = 34.5 nM
10 IC50 = 34.81 nM
11 IC50 = 37.9 nM
12 IC50 = 38.1 nM
13 IC50 = 61 nM
14 IC50 = 71 nM
15 Ki = 7 nM
CP0014425
4-[[3-[(dimethylamino)methyl]indol-1-yl]methyl]-N-hydroxybenzamide
   Show/Hide
C19H21N3O2
 1
1 IC50 = 5.012 nM
CP0014760
N-hydroxy-4-[[3-(1-methylpyrrolidin-2-yl)indol-1-yl]methyl]benzamide
   Show/Hide
C21H23N3O2
 1
1 IC50 = 5.012 nM
CP0007846
N-hydroxy-4-[(2-methyl-3,4-dihydro-1H-pyrido[4,3-b]indol-5-yl)methyl]benzamide
   Show/Hide
C20H21N3O2
 4
1 IC50 = 12.59 nM
2 IC50 = 3710 nM
3 IC50 = 25000 nM
4 IC50 > 30000 nM
CP0007527
4-[[3-[(dimethylamino)methyl]indazol-1-yl]methyl]-N-hydroxybenzamide
   Show/Hide
C18H20N4O2
 1
1 IC50 = 19.95 nM
CP0129460
US9249087, 19
   Show/Hide
C20H23N3O2
 1
1 IC50 = 19.95 nM
CP0014641
N-hydroxy-4-[[3-(3-methylimidazol-4-yl)indol-1-yl]methyl]benzamide
   Show/Hide
C20H18N4O2
 1
1 IC50 = 25.12 nM
CP0003832
N'-hydroxy-N-phenyloctanediamide
   Show/Hide
C14H20N2O3
 27
1 IC50 = 47.5 nM
2 IC50 = 50 nM
3 IC50 = 58 nM
4 IC50 = 64 nM
5 IC50 = 68.4 nM
6 IC50 = 70 nM
7 IC50 = 72 nM
8 IC50 = 80 nM
9 IC50 = 91.8 nM
10 IC50 = 97 nM
11 IC50 = 100 nM
12 IC50 = 150 nM
13 IC50 = 170 nM
14 IC50 = 199.53 nM
15 IC50 = 200 nM
16 IC50 = 210 nM
17 IC50 = 238.1 nM
18 IC50 = 278 nM
19 IC50 = 430 nM
20 IC50 = 432 nM
21 IC50 = 456 nM
22 IC50 = 460 nM
23 IC50 = 686 nM
24 IC50 = 982 nM
25 Ki = 40 nM
26 Ki = 50 nM
27 Ki = 60 nM
CP0119682
US9249087, 2
   Show/Hide
C16H14N2O2
 1
1 IC50 = 63.1 nM
CP0013041
HPOB
   Show/Hide
C17H18N2O4
 2
1 IC50 = 79.43 nM
2 IC50 = 3000 nM
CP0562872
N-hydroxy-4-[[3-(2-hydroxyethyl)indol-1-yl]methyl]benzamide
   Show/Hide
C18H18N2O3
 1
1 IC50 = 79.43 nM
CP0070180
tert-butyl N-[4-[3-[[7-(hydroxyamino)-7-oxoheptyl]carbamoyl]-1,2-oxazol-5-yl]phenyl]carbamate
   Show/Hide
C22H30N4O6
 2
1 IC50 = 90.7 nM
2 IC50 = 316.23 nM
CP0057110
4-[[butyl(phenylcarbamoyl)amino]methyl]-N-hydroxybenzamide
   Show/Hide
C19H23N3O3
 2
1 IC50 = 100 nM
2 IC50 = 7570 nM
CP0004475
RICOLINOSTAT
   Show/Hide
C24H27N5O3
 3
1 IC50 = 125.89 nM
2 IC50 = 194 nM
3 IC50 > 10000 nM
CP0064131
7-(4-(3-Ethynylphenylamino)-7-methoxyquinazolin-6-yloxy)-N-hydroxyheptanamide
   Show/Hide
C24H26N4O4
 1
1 IC50 = 125.89 nM
CP0244186
N-hydroxy-4-[[3-(2-methoxyethyl)indol-1-yl]methyl]benzamide
   Show/Hide
C19H20N2O3
 1
1 IC50 = 125.89 nM
CP0473253
tert-butyl N-[[1-[[4-(hydroxycarbamoyl)phenyl]methyl]indol-3-yl]methyl]carbamate
   Show/Hide
C22H25N3O4
 1
1 IC50 = 158.49 nM
CP0011675
N-hydroxy-4-[(2-methyl-3,4-dihydro-1H-pyrido[3,4-b]indol-9-yl)methyl]benzamide
   Show/Hide
C20H21N3O2
 1
1 IC50 = 199.53 nM
CP0053450
6-(3-adamantan-1-yl-ureido)hexanoic acid hydroxyamide
   Show/Hide
C17H29N3O3
 1
1 IC50 = 270 nM
CP0007526
US9249087, 8
   Show/Hide
C18H18N2O2
 1
1 IC50 = 316.23 nM
CP0232823
4-(3,4-dihydro-1H-thiopyrano[4,3-b]indol-5-ylmethyl)-N-hydroxybenzamide
   Show/Hide
C19H18N2O2S
 1
1 IC50 = 316.23 nM
CP0075287
4-[(2-acetyl-3,4-dihydro-1H-pyrido[4,3-b]indol-5-yl)methyl]-N-hydroxybenzamide
   Show/Hide
C21H21N3O3
 1
1 IC50 = 501.19 nM
CP0011676
4-(3,4-dihydro-1H-pyrano[4,3-b]indol-5-ylmethyl)-N-hydroxybenzamide
   Show/Hide
C19H18N2O3
 1
1 IC50 = 630.96 nM
CP0348866
N-hydroxy-4-(1,2,3,4-tetrahydrocarbazol-9-ylmethyl)benzamide
   Show/Hide
C20H20N2O2
 1
1 IC50 = 1000 nM
CP0013235
(E)-3-[2-butyl-1-[2-(diethylamino)ethyl]benzimidazol-5-yl]-N-hydroxyprop-2-enamide
   Show/Hide
C20H32Cl2N4O2
 2
1 IC50 = 1584.89 nM
2 Ki = 23 nM
CP0015005
S-[(E)-4-[(4Z,7S,10S)-4-ethylidene-2,5,8,12-tetraoxo-7-propan-2-yl-9-oxa-16-thia-3,6,13,18-tetrazabicyclo[13.2.1]octadeca-1(17),15(18)-dien-10-yl]but-3-enyl] octanethioate
   Show/Hide
C29H42N4O6S2
 1
1 IC50 = 1930 nM
CP0324814
US8748451, 5
   Show/Hide
C20H16N2O2
 1
1 IC50 = 1995.26 nM
CP0004988
pyridin-3-ylmethyl N-[[4-[(2-aminophenyl)carbamoyl]phenyl]methyl]carbamate
   Show/Hide
C21H20N4O3
 3
1 IC50 = 3150 nM
2 IC50 = 11100 nM
3 IC50 = 50100 nM
CP0238956
4-[(2-tert-butylindol-1-yl)methyl]-N-hydroxybenzamide
   Show/Hide
C20H22N2O2
 1
1 IC50 = 5011.87 nM
CP0053451
6-(2-Mercapto-acetylamino)-hexanoic acid quinolin-8-ylamide
   Show/Hide
C17H21N3O2S
 1
1 IC50 = 10650 nM
CP0014148
N-hydroxy-1-[(4-methoxyphenyl)methyl]indole-6-carboxamide
   Show/Hide
C17H16N2O3
 3
1 IC50 = 13000 nM
2 IC50 = 39810.72 nM
3 IC50 > 20000 nM
CP0008165
N'-(2-aminophenyl)-N-[3-(1-phenyltriazol-4-yl)phenyl]octanediamide
   Show/Hide
C28H30N6O2
 1
1 IC50 > 30000 nM
Clinical Information about the Protein
Target 1 ( Histone deacetylase 10 (HDAC10) )
Target Type Patented-recorded Target
Disease 1 Target-related Disease  1
1 Solid tumour/cancer [ICD-11: 2A00-2F9Z]
Investigative Drug(s) 1 Investigative Drug  1
1 ST-2987 Investigative
Solid tumour/cancer